These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12933558)

  • 1. Regression modeling of competing crude failure probabilities.
    Fine JP
    Biostatistics; 2001 Mar; 2(1):85-97. PubMed ID: 12933558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks data.
    Ng SK; McLachlan GJ
    Stat Med; 2003 Apr; 22(7):1097-111. PubMed ID: 12652556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models.
    Fiocco M; Putter H; van Houwelingen HC
    Stat Med; 2008 Sep; 27(21):4340-58. PubMed ID: 18425994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAS macros for estimation of the cumulative incidence functions based on a Cox regression model for competing risks survival data.
    Rosthøj S; Andersen PK; Abildstrom SZ
    Comput Methods Programs Biomed; 2004 Apr; 74(1):69-75. PubMed ID: 14992828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression modeling of semicompeting risks data.
    Peng L; Fine JP
    Biometrics; 2007 Mar; 63(1):96-108. PubMed ID: 17447934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regularized estimation in the accelerated failure time model with high-dimensional covariates.
    Huang J; Ma S; Xie H
    Biometrics; 2006 Sep; 62(3):813-20. PubMed ID: 16984324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial neural network for the joint modelling of discrete cause-specific hazards.
    Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
    Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials.
    Royston P; Sauerbrei W
    Stat Med; 2004 Aug; 23(16):2509-25. PubMed ID: 15287081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible hazard regression modeling for medical cost data.
    Jain AK; Strawderman RL
    Biostatistics; 2002 Mar; 3(1):101-18. PubMed ID: 12933627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.
    Datta S; Le-Rademacher J; Datta S
    Biometrics; 2007 Mar; 63(1):259-71. PubMed ID: 17447952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semiparametric approach for the nonparametric transformation survival model with multiple covariates.
    Song X; Ma S; Huang J; Zhou XH
    Biostatistics; 2007 Apr; 8(2):197-211. PubMed ID: 16670240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in postmenopausal women with hormone-receptor positive early breast cancer from a Canadian perspective.
    Delea TE; El-Ouagari K; Karnon J; Sofrygin O
    Breast Cancer Res Treat; 2008 Apr; 108(3):375-87. PubMed ID: 17653859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE
    Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulating competing risks data in survival analysis.
    Beyersmann J; Latouche A; Buchholz A; Schumacher M
    Stat Med; 2009 Mar; 28(6):956-71. PubMed ID: 19125387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A competing-risks nomogram for sarcoma-specific death following local recurrence.
    Kattan MW; Heller G; Brennan MF
    Stat Med; 2003 Nov; 22(22):3515-25. PubMed ID: 14601016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constrained parametric model for simultaneous inference of two cumulative incidence functions.
    Shi H; Cheng Y; Jeong JH
    Biom J; 2013 Jan; 55(1):82-96. PubMed ID: 23090878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-parametric estimation of gap time survival functions for ordered multivariate failure time data.
    Schaubel DE; Cai J
    Stat Med; 2004 Jun; 23(12):1885-900. PubMed ID: 15195322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.